How long can a midline catheter stay in place for a patient receiving Vabomere (meropenem and vaborbactam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midline Catheter Dwell Time

Midline catheters do not require routine replacement to reduce infection risk and can remain in place as long as they are functioning properly without signs of complications. 1, 2

No Maximum Dwell Time Based on Duration Alone

  • The CDC explicitly states that midline catheters should not be routinely replaced to prevent infection, with no predetermined maximum dwell time specified. 1, 2
  • The infection risk with midline catheters does not increase with duration of catheterization, with a bloodstream infection rate of only 0.8 per 1,000 catheter-days. 2
  • Prospective studies document safe use with median dwell times of 7 days and documented safe use up to 49 days. 2
  • Research demonstrates midline catheters can remain in place for 2-6 weeks routinely, with some reports of safe use extending to several months (up to 365 days in palliative care settings). 3, 1

Indications-Based Removal Only

Remove the midline catheter only when specific clinical indications arise, not based on arbitrary time limits. 2

Remove immediately if any of the following develop:

  • Signs of phlebitis (warmth, tenderness, erythema, palpable venous cord) 1, 2
  • Evidence of infection (fever, purulent drainage, systemic symptoms) 2
  • Catheter malfunction (occlusion, inability to aspirate or flush) 2
  • Catheter dislodgement or damage 2

Appropriate Duration for Vabomere Administration

For patients receiving Vabomere (meropenem-vaborbactam), which is a peripherally compatible infusate:

  • Midline catheters are appropriate for therapy durations of 6-14 days. 1
  • For critically ill patients, midline catheters are rated as appropriate for peripherally compatible infusates when the proposed duration is 6-14 days. 1
  • If therapy extends beyond 14 days, consider transitioning to a PICC line, though a well-functioning midline can remain if no complications develop. 1

Daily Monitoring Requirements

Evaluate the catheter insertion site daily by palpation through the dressing to detect tenderness. 2

  • Perform visual inspection if using a transparent dressing. 1, 2
  • Remove opaque dressings only if clinical signs of infection develop. 1, 2
  • Assess catheter patency and flow daily. 2

Critical Pitfalls to Avoid

  • Do not apply arbitrary time limits for midline removal based solely on duration, as this is not supported by evidence. 2
  • Do not routinely apply prophylactic topical antimicrobials to the insertion site. 1, 2
  • Do not leave the catheter in place if signs of phlebitis or infection develop—removal is mandatory, not optional. 1, 2
  • Periodically reassess whether the catheter is still needed, as unnecessary catheter days increase infection risk. 2

Real-World Complication Data

Recent studies demonstrate favorable safety profiles:

  • In a prospective study of 403 midline catheters in critically ill ED patients, the median dwell time was 5 days (range 2-8 days), with severe complications occurring in only 0.7% of patients. 4
  • A randomized controlled trial showed median overall catheter dwell time of 7 days (range 0-60 days) with successful completion of therapy in 80.9% of patients. 5
  • A 3-year retrospective study found median dwell time of 11 days with major complications (VTE or CRBSI) occurring in only 0.9% of patients. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midline Catheter Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Medial venous catheter or midline (MVC)].

Revista de enfermeria (Barcelona, Spain), 2014

Research

The efficacy of midline catheters-a prospective, randomized, active-controlled study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.